Xtant Medical has secured CE mark approval for its two products, Aranax and Irix-A.
Aranax is a cervical plating system, while Irix-A is a stand-alone anterior lumbar interbody fusion device.
The company will distribute the Aranax as a pre-sterilized and ready-to-use implant. The Irix-A features a titanium ring, surrounded by a PEEK shell.
Xtant Medical executive vice president and chief scientific officer David Kirschman said: "We are very pleased to have received these additional clearances for our best in class medical devices.
"They will allow us to expand our distribution presence and better serve the surgical needs of our customers internationally."
The company is showcasing both the products and other orthopedic products at the AAOS Annual Meeting in Orlando, Florida, US.
Last December, the firm received CE mark approval for its Certex OCT spinal fixation system, which will be used in the fusion of the occipito-cervico-thoracic regions of the spine (Occiput-T3 inclusive).
Xtant Medical produces and markets medicine products and medical devices for domestic and international markets.
The firm has implants and instrumentation for the treatment of spinal disease, tissue grafts to treat orthopedic disorders, as well as biologics to promote healing following cranial, and foot and ankle surgeries.